Abstract: The present disclosure provides for a a peptide mixture comprising: a) a first peptide having an amino acid sequence as set forth in SEQ ID NO: 1; b) a second peptide having an amino acid sequence as set forth in SEQ ID NO: 2; c) a third peptide having an amino acid sequence as set forth in SEQ ID NO: 3; and d) a fourth peptide having an amino acid sequence as set forth in SEQ ID NO: 4. The present disclosure further provides a composition comprising the peptide mixture as described herein and at least one iron salt. The process for preparing the composition and the peptide mixture has also been disclosed herein.
I/We Claim:
1. A peptide mixture comprising:
a) a first peptide having an amino acid sequence as set forth in SEQ ID NO: 1;
b) a second peptide having an amino acid sequence as set forth in SEQ ID NO: 2;
c) a third peptide having an amino acid sequence as set forth in SEQ ID NO: 3; and
d) a fourth peptide having an amino acid sequence as set forth in SEQ ID NO: 4.
2. The peptide mixture as claimed in claim 1, wherein the mixture has a protein concentration in a range of 1-2 mg/ml with respect to the mixture.
3. A composition comprising:
(i) a peptide mixture comprising:
a) a first peptide having an amino acid sequence as set forth in SEQ ID NO: 1;
b) a second peptide having an amino acid sequence as set forth in SEQ ID NO: 2
c) a third peptide having an amino acid sequence as set forth in SEQ ID NO: 3;
d) a fourth peptide having an amino acid sequence as set forth in SEQ ID NO: 4; and
(ii) at least one iron salt.
4. The composition as claimed in claim 3, wherein the peptide mixture has a protein concentration in a range of 1-2 mg/ml with respect to the mixture
5. The composition as claimed in claim 3, wherein the peptide mixture and the at least one iron salt has a weight ratio in a range of 1:5 to 1:0.3.
6. The composition as claimed in claim 3, wherein the at least one iron salt is selected from a group consisting of ferrous sulphate, ferric pyrophosphate, ferrous gluconate, ferrous fumarate, anhydrous ferrous carbonate, carbonyl
iron, ferric ammonium citrate, iron choline citrate, and combinations thereof.
7. The composition as claimed in claim 3, wherein the at least one iron salt is ferrous sulphate.
8. A process for preparing the peptide mixture as claimed in claim 1, said process comprises:
a) obtaining a first peptide having an amino acid sequence as set forth in SEQ ID NO: 1;
b) obtaining a second peptide having an amino acid sequence as set forth in SEQ ID NO: 2;
c) obtaining a third peptide having an amino acid sequence as set forth in SEQ ID NO: 3;
d) obtaining a fourth peptide having an amino acid sequence as set forth in SEQ ID NO: 4; and
e) contacting the first peptide, the second peptide, the third peptide, and the fourth peptide, to obtain the peptide mixture.
9. A process for preparing the composition as claimed in claim 3, said process
comprises:
a) obtaining a first peptide having an amino acid sequence as set forth in SEQ ID NO: 1;
b) obtaining a second peptide having an amino acid sequence as set forth in SEQ ID NO: 2;
c) obtaining a third peptide having an amino acid sequence as set forth in SEQ ID NO: 3;
d) obtaining a fourth peptide having an amino acid sequence as set forth in SEQ ID NO: 4;
e) contacting the first peptide, the second peptide, the third peptide, and the fourth peptide, to obtain the peptide mixture; and
f) contacting the peptide mixture to the at least one iron salt, to obtain the composition.
10. The peptide mixture as claimed in claim 1, said mixture enhances iron absorption by intestinal cells.
| # | Name | Date |
|---|---|---|
| 1 | 201941013686-FORM 18 [20-03-2023(online)].pdf | 2023-03-20 |
| 1 | 201941013686-STATEMENT OF UNDERTAKING (FORM 3) [04-04-2019(online)].pdf | 2019-04-04 |
| 2 | 201941013686-SEQUENCE LISTING(PDF) [04-04-2019(online)].pdf | 2019-04-04 |
| 2 | Correspondence by Agent _Proof of Right,Power of Attorney_17-06-2019.pdf | 2019-06-17 |
| 3 | 201941013686-SEQUENCE LISTING [04-04-2019(online)].txt | 2019-04-04 |
| 3 | 201941013686-FORM-26 [13-06-2019(online)].pdf | 2019-06-13 |
| 4 | 201941013686-Proof of Right (MANDATORY) [13-06-2019(online)].pdf | 2019-06-13 |
| 4 | 201941013686-FORM 1 [04-04-2019(online)].pdf | 2019-04-04 |
| 5 | 201941013686-COMPLETE SPECIFICATION [04-04-2019(online)].pdf | 2019-04-04 |
| 5 | 201941013686-DRAWINGS [04-04-2019(online)].pdf | 2019-04-04 |
| 6 | 201941013686-DECLARATION OF INVENTORSHIP (FORM 5) [04-04-2019(online)].pdf | 2019-04-04 |
| 7 | 201941013686-COMPLETE SPECIFICATION [04-04-2019(online)].pdf | 2019-04-04 |
| 7 | 201941013686-DRAWINGS [04-04-2019(online)].pdf | 2019-04-04 |
| 8 | 201941013686-FORM 1 [04-04-2019(online)].pdf | 2019-04-04 |
| 8 | 201941013686-Proof of Right (MANDATORY) [13-06-2019(online)].pdf | 2019-06-13 |
| 9 | 201941013686-FORM-26 [13-06-2019(online)].pdf | 2019-06-13 |
| 9 | 201941013686-SEQUENCE LISTING [04-04-2019(online)].txt | 2019-04-04 |
| 10 | Correspondence by Agent _Proof of Right,Power of Attorney_17-06-2019.pdf | 2019-06-17 |
| 10 | 201941013686-SEQUENCE LISTING(PDF) [04-04-2019(online)].pdf | 2019-04-04 |
| 11 | 201941013686-STATEMENT OF UNDERTAKING (FORM 3) [04-04-2019(online)].pdf | 2019-04-04 |
| 11 | 201941013686-FORM 18 [20-03-2023(online)].pdf | 2023-03-20 |